Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib plus UVB phototherapy vs UVB alone in adults with progressive vitiligo
2020-005079-12Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Feb 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of baricitinib in Vitiligo (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Mean variation in percentage of Vitiligo Area Scoring Index (VASI). Started Feb 2021; status: completed.
02
Drugs
baricitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2020-005079-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005079-12.